Literature DB >> 24838299

Health-related quality of life in adolescents with inflammatory bowel disease depends on disease activity and psychiatric comorbidity.

G Engelmann1, D Erhard, M Petersen, P Parzer, A A Schlarb, F Resch, R Brunner, G F Hoffmann, H Lenhartz, A Richterich.   

Abstract

Adolescent patients with inflammatory bowel disease (IBD) show an increased risk for behavioral and emotional dysfunction. Health-related quality of life (HRQoL) is influenced by medical illnesses, as well as by psychiatric disorders, but for adolescents with IBD, the extent to which HRQoL is influenced by these two factors is unclear. For 47 adolescent IBD patients, we analyzed disease activity, HRQoL and whether or not a psychiatric disorder was present. Disease activity was estimated using pediatric Ulcerative Colitis Activity Index and pediatric Crohn's Disease Activity Index. The IMPACT-III and the EQ-5D were used to measure HRQoL and QoL, respectively. In addition, patient and parent diagnostic interviews were performed. 55.3 % patients fulfilled DSM-IV criteria for one or more psychiatric disorders. In all patients, psychiatric comorbidity together with disease activity contributed to a reduction in quality of life. Adolescents with IBD are at a high risk for clinically relevant emotional or behavioral problems resulting in significantly lower HRQoL. We conclude that accessible, optimally structured psychotherapeutic and/or psychiatric help is needed in adolescent patients with IBD.

Entities:  

Mesh:

Year:  2015        PMID: 24838299     DOI: 10.1007/s10578-014-0471-5

Source DB:  PubMed          Journal:  Child Psychiatry Hum Dev        ISSN: 0009-398X


  33 in total

1.  Family interaction and locus of control in children and adolescents with inflammatory bowel disease.

Authors:  I Engström
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  1991-11       Impact factor: 8.829

Review 2.  Inflammatory bowel disease.

Authors:  Eva Szigethy; Laura McLafferty; Alka Goyal
Journal:  Child Adolesc Psychiatr Clin N Am       Date:  2010-04

3.  Quality of life assessment: The world health organization perspective.

Authors:  S Saxena; J Orley
Journal:  Eur Psychiatry       Date:  1997       Impact factor: 5.361

Review 4.  Cognitive-behavioral therapy for children with comorbid physical illness.

Authors:  Rachel D Thompson; Patty Delaney; Inti Flores; Eva Szigethy
Journal:  Child Adolesc Psychiatr Clin N Am       Date:  2011-02-16

5.  Inflammatory bowel disease in children and adolescents: recommendations for diagnosis--the Porto criteria.

Authors: 
Journal:  J Pediatr Gastroenterol Nutr       Date:  2005-07       Impact factor: 2.839

6.  Depression and anxiety in pediatric inflammatory bowel disease and cystic fibrosis.

Authors:  P Burke; V Meyer; S Kocoshis; D M Orenstein; R Chandra; D J Nord; J Sauer; E Cohen
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  1989-11       Impact factor: 8.829

7.  Longitudinal results of cognitive behavioral treatment for youths with inflammatory bowel disease and depressive symptoms.

Authors:  Rachel D Thompson; Anna Craig; Emily A Crawford; Diane Fairclough; Joseph Gonzalez-Heydrich; Athos Bousvaros; Robert B Noll; David R DeMaso; Eva Szigethy
Journal:  J Clin Psychol Med Settings       Date:  2012-09

Review 8.  Psychosocial issues in pediatric inflammatory bowel disease: report of the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition.

Authors:  Laura M Mackner; Rachel Neff Greenley; Eva Szigethy; Michele Herzer; Kate Deer; Kevin A Hommel
Journal:  J Pediatr Gastroenterol Nutr       Date:  2013-04       Impact factor: 2.839

9.  Inflammatory bowel disease: a study of the association between anxiety and depression, physical morbidity, and nutritional status.

Authors:  G Addolorato; E Capristo; G F Stefanini; G Gasbarrini
Journal:  Scand J Gastroenterol       Date:  1997-10       Impact factor: 2.423

Review 10.  A review of health utilities across conditions common in paediatric and adult populations.

Authors:  Jean-Eric Tarride; Natasha Burke; Matthias Bischof; Robert B Hopkins; Linda Goeree; Kaitryn Campbell; Feng Xie; Daria O'Reilly; Ron Goeree
Journal:  Health Qual Life Outcomes       Date:  2010-01-27       Impact factor: 3.186

View more
  15 in total

1.  Effectiveness of Disease-Specific Cognitive Behavioral Therapy on Anxiety, Depression, and Quality of Life in Youth With Inflammatory Bowel Disease: A Randomized Controlled Trial.

Authors:  Luuk Stapersma; Gertrude van den Brink; Jan van der Ende; Eva M Szigethy; Ruud Beukers; Thea A Korpershoek; Sabine D M Theuns-Valks; Manon H J Hillegers; Johanna C Escher; Elisabeth M W J Utens
Journal:  J Pediatr Psychol       Date:  2018-10-01

Review 2.  Inflammatory Bowel Disease in Childhood and Adolescence.

Authors:  Jan Däbritz; Patrick Gerner; Axel Enninger; Martin Claßen; Michael Radke
Journal:  Dtsch Arztebl Int       Date:  2017-05-12       Impact factor: 5.594

Review 3.  Pediatric inflammatory bowel disease and depression: treatment implications.

Authors:  Divya Keethy; Christine Mrakotsky; Eva Szigethy
Journal:  Curr Opin Pediatr       Date:  2014-10       Impact factor: 2.856

4.  Effects of a Cognitive Behavioral Therapy Intervention Trial to Improve Disease Outcomes in Children with Inflammatory Bowel Disease.

Authors:  Rona L Levy; Miranda A L van Tilburg; Shelby L Langer; Joan M Romano; Lynn S Walker; Lloyd A Mancl; Tasha B Murphy; Robyn L Claar; Shara I Feld; Dennis L Christie; Bisher Abdullah; Melissa M DuPen; Kimberly S Swanson; Melissa D Baker; Susan A Stoner; William E Whitehead
Journal:  Inflamm Bowel Dis       Date:  2016-09       Impact factor: 5.325

Review 5.  Ulcerative Colitis-Diagnostic and Therapeutic Algorithms.

Authors:  Torsten Kucharzik; Sibylle Koletzko; Klaus Kannengiesser; Axel Dignass
Journal:  Dtsch Arztebl Int       Date:  2020-08-17       Impact factor: 5.594

Review 6.  Neuroimmune pharmacological approaches.

Authors:  Peter Holzer; Ahmed M Hassan; Piyush Jain; Florian Reichmann; Aitak Farzi
Journal:  Curr Opin Pharmacol       Date:  2015-09-29       Impact factor: 5.547

7.  Reduction in Anxiety and Depression Scores Associated with Improvement in Quality of Life in Patients with Inflammatory Bowel Disease.

Authors:  Yasamin Farbod; Jelena Popov; David Armstrong; Smita Halder; John K Marshall; Frances Tse; Maria Ines Pinto-Sanchez; Paul Moayyedi; Usha Chauhan
Journal:  J Can Assoc Gastroenterol       Date:  2021-05-19

8.  Effectiveness of disease-specific cognitive-behavioural therapy on depression, anxiety, quality of life and the clinical course of disease in adolescents with inflammatory bowel disease: study protocol of a multicentre randomised controlled trial (HAPPY-IBD).

Authors:  Gertrude van den Brink; Luuk Stapersma; Hanan El Marroun; Jens Henrichs; Eva M Szigethy; Elisabeth Mwj Utens; Johanna C Escher
Journal:  BMJ Open Gastroenterol       Date:  2016-03-02

9.  Disease impact on the quality of life of children with inflammatory bowel disease.

Authors:  Giorgos Chouliaras; Daphne Margoni; Konstantina Dimakou; Smaragdi Fessatou; Ioanna Panayiotou; Eleftheria Roma-Giannikou
Journal:  World J Gastroenterol       Date:  2017-02-14       Impact factor: 5.742

10.  The Impact of Inflammatory Bowel Disease in Canada 2018: Quality of Life.

Authors:  Jennifer L Jones; Geoffrey C Nguyen; Eric I Benchimol; Charles N Bernstein; Alain Bitton; Gilaad G Kaplan; Sanjay K Murthy; Kate Lee; Jane Cooke-Lauder; Anthony R Otley
Journal:  J Can Assoc Gastroenterol       Date:  2018-11-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.